Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Association of breast tumour bed seroma with post-operative complications and late normal tissue toxicity: results from the Cambridge Breast IMRT trial.

Mukesh MB, Barnett G, Cumming J, Wilkinson JS, Moody AM, Wilson C, Wishart GC, Coles CE.

Eur J Surg Oncol. 2012 Oct;38(10):918-24. doi: 10.1016/j.ejso.2012.05.008. Epub 2012 Jun 14.

PMID:
22704052
2.

The Cambridge Breast Intensity-modulated Radiotherapy Trial: patient- and treatment-related factors that influence late toxicity.

Barnett GC, Wilkinson JS, Moody AM, Wilson CB, Twyman N, Wishart GC, Burnet NG, Coles CE.

Clin Oncol (R Coll Radiol). 2011 Dec;23(10):662-73. doi: 10.1016/j.clon.2011.04.011. Epub 2011 Jun 8.

PMID:
21646002
3.

Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis.

Mukesh MB, Barnett GC, Wilkinson JS, Moody AM, Wilson C, Dorling L, Chan Wah Hak C, Qian W, Twyman N, Burnet NG, Wishart GC, Coles CE.

J Clin Oncol. 2013 Dec 20;31(36):4488-95. doi: 10.1200/JCO.2013.49.7842. Epub 2013 Sep 16.

PMID:
24043742
4.

Randomized controlled trial of forward-planned intensity modulated radiotherapy for early breast cancer: interim results at 2 years.

Barnett GC, Wilkinson JS, Moody AM, Wilson CB, Twyman N, Wishart GC, Burnet NG, Coles CE.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):715-23. doi: 10.1016/j.ijrobp.2010.10.068. Epub 2011 Feb 23.

PMID:
21345620
5.

Prospective randomized comparison of conventional instruments and the Harmonic Focus(®) device in breast-conserving therapy for primary breast cancer.

Böhm D, Kubitza A, Lebrecht A, Schmidt M, Gerhold-Ay A, Battista M, Stewen K, Solbach C, Kölbl H.

Eur J Surg Oncol. 2012 Feb;38(2):118-24. doi: 10.1016/j.ejso.2011.11.003. Epub 2011 Dec 5.

PMID:
22152942
6.

Association between operative closure type and acute infection, local recurrence, and disease surveillance in patients undergoing breast conserving therapy for early-stage breast cancer.

Indelicato D, Grobmyer SR, Newlin H, Morris CG, Haigh LS, Copeland EM 3rd, Mendenhall NP.

Surgery. 2007 May;141(5):645-53.

PMID:
17462465
7.
8.

Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy.

Donovan E, Bleakley N, Denholm E, Evans P, Gothard L, Hanson J, Peckitt C, Reise S, Ross G, Sharp G, Symonds-Tayler R, Tait D, Yarnold J; Breast Technology Group.

Radiother Oncol. 2007 Mar;82(3):254-64. Epub 2007 Jan 16.

PMID:
17224195
9.

[Ultraconservative treatment in stage I and II breast carcinoma. Results of a long-term follow-up on 500 operated breasts].

Mencacci R, Alessandroni L, Arcangeli G, Bertolini R, Cecera A, Lopez M, Mardarella C, Parisi A, Tersigni R.

Minerva Chir. 2010 Aug;65(4):401-7. Italian.

PMID:
20802429
10.

Complications in breast surgery.

Vitug AF, Newman LA.

Surg Clin North Am. 2007 Apr;87(2):431-51, x. Review.

PMID:
17498536
11.

Comparison of chronic toxicities between brachytherapy-based accelerated partial breast irradiation and whole breast irradiation using intensity modulated radiotherapy.

Wobb JL, Shah C, Jawad MS, Wallace M, Dilworth JT, Grills IS, Ye H, Chen PY.

Breast. 2015 Dec;24(6):739-44. doi: 10.1016/j.breast.2015.09.004. Epub 2015 Oct 12.

PMID:
26459227
12.

Comparison of conventional radiotherapy and intensity-modulated radiotherapy for post-operative radiotherapy for primary extremity soft tissue sarcoma.

Stewart AJ, Lee YK, Saran FH.

Radiother Oncol. 2009 Oct;93(1):125-30. doi: 10.1016/j.radonc.2009.06.010. Epub 2009 Jul 13.

PMID:
19604591
13.

Postmastectomy breast reconstruction after previous lumpectomy and radiation therapy: analysis of complications and satisfaction.

Khansa I, Colakoglu S, Curtis MS, Yueh JH, Ogunleye A, Tobias AM, Lee BT.

Ann Plast Surg. 2011 May;66(5):444-51. doi: 10.1097/SAP.0b013e3182166b81.

PMID:
21451371
14.

Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.

Jenkinson AD, Al-Mufti RA, Mohsen Y, Berry MJ, Wells C, Carpenter R.

Eur J Surg Oncol. 2001 Feb;27(1):21-5.

PMID:
11237487
15.

Surgical treatment for invasive lobular carcinoma of the breast.

Hussien M, Lioe TF, Finnegan J, Spence RA.

Breast. 2003 Feb;12(1):23-35.

PMID:
14659352
16.

A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis.

Pignol JP, Olivotto I, Rakovitch E, Gardner S, Sixel K, Beckham W, Vu TT, Truong P, Ackerman I, Paszat L.

J Clin Oncol. 2008 May 1;26(13):2085-92. doi: 10.1200/JCO.2007.15.2488. Epub 2008 Feb 19.

PMID:
18285602
17.

Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.

Leong C, Boyages J, Jayasinghe UW, Bilous M, Ung O, Chua B, Salisbury E, Wong AY.

Cancer. 2004 May 1;100(9):1823-32.

18.

Cosmetic outcome and seroma formation after breast-conserving surgery with intraoperative radiation therapy boost for early breast cancer.

Senthi S, Link E, Chua BH.

Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):e139-44. doi: 10.1016/j.ijrobp.2012.03.015. Epub 2012 May 5.

PMID:
22560552
20.

The effect of dedicated breast surgeons on the short-term outcomes in breast cancer.

Zork NM, Komenaka IK, Pennington RE Jr, Bowling MW, Norton LE, Clare SE, Goulet RJ Jr.

Ann Surg. 2008 Aug;248(2):280-5. doi: 10.1097/SLA.0b013e3181784647.

PMID:
18650639

Supplemental Content

Support Center